1.in very competitive price;2.quality guaranteed;3.fast delivery;4.financial credit supportc
Main Markets: | North America | ||
Total Annual Sales Volume: | Above US$100 Million | ||
Export Percentage: | 90% - 99% | ||
Total Annual Purchase Volume: | Above US$100 Million | ||
Trade Shows: | FCI, CPHI, VIV | ||
Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body mass.
The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).[11]
